Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

NCT01316458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasm
Genital Neoplasms, Male
Neoplasms, Abdominal
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Diseases
Antineoplastic Agents
Imatinib

Interventions

DRUG: STI571 (Glivec®)

Sponsor

Novartis Pharmaceuticals